المؤلفون: Yang X; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Lu X; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Feng L; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Wang W; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Kan Y; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Zhang S; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China., Li X; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, Wien, Vienna, 1090, Austria. xiang.li@meduniwien.ac.at., Yang J; Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong An Road, Xi Cheng District, Beijing, 100050, China. yangjigang@ccmu.edu.cn.

المصدر: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Aug 18; Vol. 24 (1), pp. 108. Date of Electronic Publication: 2024 Aug 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Fluorodeoxyglucose F18* , Positron Emission Tomography Computed Tomography*/methods , Lymphohistiocytosis, Hemophagocytic*/diagnostic imaging , Lymphohistiocytosis, Hemophagocytic*/virology , Epstein-Barr Virus Infections*/complications , Epstein-Barr Virus Infections*/diagnostic imaging , Nomograms*, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Radiopharmaceuticals ; Herpesvirus 4, Human/isolation & purification ; Prognosis ; Lymphoma/diagnostic imaging ; Lymphoma/virology

المؤلفون: Tang Z; Academy of Pediatrics, University of South China, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Zhu D; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Li X; Pediatric Research Institute of Hunan Province and Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China., Yan H; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Luo T; Pediatric Research Institute of Hunan Province and Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China., Xie L; Pediatric Research Institute of Hunan Province and Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China., Yang Y; Pediatric Research Institute of Hunan Province and Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China., Tang M; Academy of Pediatrics, University of South China, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Jiang X; Academy of Pediatrics, University of South China, Changsha, China.; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Huang J; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Zhang X; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Zhou L; Pediatric Intensive Care Unit (PICU), The First People's Hospital of Chenzhou, Chenzhou, China., Lei Y; Pediatric Intensive Care Unit (PICU), The First People's Hospital of Chenzhou, Chenzhou, China., Xiao Z; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China., Lu X; Hunan Provincial Key Laboratory of Emergency Medicine for Children, Hunan Children's Hospital, Changsha, China. 13787252674@163.com.; Pediatric Intensive Care Unit (PICU), Hunan Children's Hospital, Changsha, China. 13787252674@163.com.

المصدر: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 2699-2709. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article; Validation Study; Comparative Study

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/mortality , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/blood, Humans ; Female ; Male ; Child, Preschool ; Child ; Infant ; Risk Assessment ; Severity of Illness Index ; Adolescent ; Nomograms ; Retrospective Studies ; ROC Curve ; Risk Factors

عنوان ترانسليتريتد: Kombinierte Immunsuppression mit Cyclosporin A, Mycophenolatmofetil (MMF) und Dexamethason zur Aktivitätskontrolle einer rezidivierten, sekundären hämophagozytischen Lymphohistiozytose (sHLH) auf dem Boden eines systemischen Lupus erythematodes (SLE).

المؤلفون: Saleh M; Klinik für Hämatologie und Onkologie, Heinrich Braun Klinikum, Karl-Keil-Straße 35, 08060, Zwickau, Deutschland. Modar.Saleh@hbk-zwickau.de., Hampel K; Klinik für Hämatologie und Onkologie, Heinrich Braun Klinikum, Karl-Keil-Straße 35, 08060, Zwickau, Deutschland., Gerth J; Klinik für Nephrologie, Heinrich Braun Klinikum, Zwickau, Deutschland., Merkelbach S; Klinik für Neurologie, Heinrich Braun Klinikum, Zwickau, Deutschland., Monecke A; Institut für Pathologie, Universitätsklinikum Leipzig, Leipzig, Deutschland., Mügge LO; Klinik für Hämatologie und Onkologie, Heinrich Braun Klinikum, Karl-Keil-Straße 35, 08060, Zwickau, Deutschland.

المصدر: Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2024 Aug; Vol. 65 (8), pp. 843-849. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Case Reports; Journal Article; English Abstract

بيانات الدورية: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384885306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2731-7099 (Electronic) Linking ISSN: 27317080 NLM ISO Abbreviation: Inn Med (Heidelb) Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/drug therapy , Lymphohistiocytosis, Hemophagocytic*/pathology , Dexamethasone*/therapeutic use , Dexamethasone*/administration & dosage , Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/drug therapy , Mycophenolic Acid*/therapeutic use , Cyclosporine*/therapeutic use , Cyclosporine*/administration & dosage , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Drug Therapy, Combination*, Humans ; Female ; Adult ; Recurrence

المؤلفون: Rafati M; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. Electronic address: maryam.rafati@nih.gov., McReynolds LJ; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Wang Y; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Jones K; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Spellman SR; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, Minnesota., He M; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, Minnesota., Bolon YT; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, Minnesota., Arrieta-Bolaños E; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Heidelberg, Germany., Saultz JN; Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon., Lee SJ; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug; Vol. 30 (8), pp. 770.e1-770.e10. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/genetics , Lymphohistiocytosis, Hemophagocytic*/therapy , Anemia, Aplastic*/genetics , Anemia, Aplastic*/therapy , Hematopoietic Stem Cell Transplantation*, Humans ; Female ; Male ; Adult ; Child ; Adolescent ; Child, Preschool ; Young Adult ; Middle Aged ; Treatment Outcome ; Genetic Variation ; Infant

المؤلفون: Zhang W; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Yin Y; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Li Y; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Cheng L; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Zhao L; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Peng Y; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. 250052272@qq.com., Wu X; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. xwu@hust.edu.cn.

المصدر: Italian journal of pediatrics [Ital J Pediatr] 2024 Jul 30; Vol. 50 (1), pp. 139. Date of Electronic Publication: 2024 Jul 30.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101510759 Publication Model: Electronic Cited Medium: Internet ISSN: 1824-7288 (Electronic) Linking ISSN: 17208424 NLM ISO Abbreviation: Ital J Pediatr Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/blood , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/virology , DNA, Viral*/blood , Epstein-Barr Virus Infections*/blood , Epstein-Barr Virus Infections*/diagnosis , Epstein-Barr Virus Infections*/complications , Herpesvirus 4, Human*/genetics, Humans ; Retrospective Studies ; Male ; Female ; Child ; Child, Preschool ; China ; Prognosis ; Infant ; Viral Load ; Adolescent ; East Asian People

المؤلفون: Liu H; Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730, China., Huang X; Department of General Practice (General Internal Medicine), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730, China., Jiao Y; Department of General Practice (General Internal Medicine), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing, 100730, China. peterpumch@163.com.

المصدر: BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 747. Date of Electronic Publication: 2024 Jul 29.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/drug therapy , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Meningoencephalitis*/drug therapy , Meningoencephalitis*/microbiology , Meningoencephalitis*/complications , Antitubercular Agents*/therapeutic use, Humans ; Male ; Aged ; Psoas Abscess/microbiology ; Psoas Abscess/drug therapy ; Tuberculosis/complications ; Tuberculosis/drug therapy ; Abscess/microbiology ; Abscess/drug therapy

المؤلفون: Huang L; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Tan J; Second Clinical College, Guangzhou Medical University, Guangzhou, China., Lin P; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Chen Z; Second Clinical College, Guangzhou Medical University, Guangzhou, China., Huang Q; Second Clinical College, Guangzhou Medical University, Guangzhou, China., Yao H; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Jiang L; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Long B; First Clinical College, Changsha Medical University, Changsha, Hunan, China., Long Y; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and The Ministry of Education of China, Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 22; Vol. 15, pp. 1383255. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/etiology , Encephalitis*/diagnosis , Encephalitis*/immunology , Hashimoto Disease*/complications , Hashimoto Disease*/diagnosis, Humans ; Female ; Middle Aged ; Adult ; Autoantibodies/blood ; Autoantibodies/immunology ; Autoantibodies/cerebrospinal fluid ; Magnetic Resonance Imaging ; Retrospective Studies

SCR Disease Name: Hashimoto's encephalitis

المؤلفون: Wen J; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.; Department of Hematology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China., Xu J; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China., Ji J; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China., Zhang W; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China., Zheng Q; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China., Liu T; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China., Zheng Y; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China., Ma H; Department of Hematology/Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 12; Vol. 15, pp. 1403376. Date of Electronic Publication: 2024 Jul 12 (Print Publication: 2024).

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/etiology , Lymphohistiocytosis, Hemophagocytic*/complications , Lymphohistiocytosis, Hemophagocytic*/drug therapy , Capillary Leak Syndrome*/etiology , Capillary Leak Syndrome*/diagnosis , Capillary Leak Syndrome*/therapy , Lymphoma, Large B-Cell, Diffuse*/complications , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/diagnosis , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Vincristine/therapeutic use ; Male ; Cyclophosphamide/therapeutic use ; Prednisone/therapeutic use ; Doxorubicin/therapeutic use ; Doxorubicin/administration & dosage ; Rituximab/therapeutic use ; Middle Aged

المؤلفون: Hu J; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wang J; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wang Z; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 08; Vol. 15, pp. 1415597. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Etoposide*/administration & dosage , Etoposide*/adverse effects , Etoposide*/therapeutic use , Lymphohistiocytosis, Hemophagocytic*/drug therapy , Lymphohistiocytosis, Hemophagocytic*/mortality , Benzamides*/administration & dosage , Benzamides*/adverse effects , Benzamides*/therapeutic use , Glucocorticoids*/administration & dosage , Glucocorticoids*/therapeutic use , Glucocorticoids*/adverse effects , Aminopyridines*/administration & dosage , Aminopyridines*/adverse effects , Aminopyridines*/therapeutic use, Humans ; Male ; Female ; Adult ; Middle Aged ; Treatment Outcome ; Aged ; Drug Therapy, Combination ; Histone Deacetylase Inhibitors/therapeutic use ; Histone Deacetylase Inhibitors/adverse effects ; Histone Deacetylase Inhibitors/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Jin Z; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Miao Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Zhang J; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China.; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China., Zhang J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China., Wang C; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The First People's Hospital of Huai'an, Huai'an, China., Lu X; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Changzhou No.2 Hospital of Nanjing Medical University, Changzhou, China., Miao Y; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Yancheng First People's Hospital, Yancheng, China., Sun M; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, China., Zhang Y; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, China., Zhuang Y; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Wu Xi People's Hospital, Wuxi, China., Ni H; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China., Xu J; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China., Zhuang W; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Second People's Hospital of Lianyungang, Lianyungang, China., Zhao M; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Wuhu Second People's Hospital, Wuhu, China., Zhu J; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China., Xu M; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, China., Lin G; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, China., Hua H; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Affiliated Hospital of Jiangnan University, Wuxi, China., Xie X; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China., Xu M; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, China., Jia T; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The First People's Hospital of Lianyungang, Lianyungang, China., Zhai L; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China., Gu W; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China., Shan Q; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Shuyang Traditional Chinese Medicine Hospital, Shuyang, China., Wang Z; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, Wuxi Second People's Hospital, Wuxi, China., Shen Q; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China.; Department of Hematology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China., Zhang X; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China. zhxh424@163.com.; Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, China. zhxh424@163.com., Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. lijianyonglm@126.com.; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China. lijianyonglm@126.com., Shi W; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China. shiwenyu@hotmail.com.; Jiangsu Cooperative Lymphoma Group (JCLG) and Jiangsu Histiocytosis Association Lymphoma Group (JHA-LG), Nanjing, China. shiwenyu@hotmail.com.

المصدر: Annals of hematology [Ann Hematol] 2024 Jul; Vol. 103 (7), pp. 2257-2266. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/blood , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/mortality , Lymphohistiocytosis, Hemophagocytic*/etiology , beta 2-Microglobulin*/blood , Lymphoma*/blood , Lymphoma*/diagnosis , Lymphoma*/complications , Lymphoma*/mortality, Humans ; Female ; Male ; Middle Aged ; Adult ; Aged ; Retrospective Studies ; Prognosis ; Aged, 80 and over ; Young Adult ; Adolescent ; Survival Rate ; Clinical Relevance